ADVFN - Advanced Financial Network.
HOME» NYSE » O » OCR Stock Price » OCR Stock News

Omnicare Share News

 Omnicare Inc. Stock Price
OCR Stock Price
 Omnicare Inc. Stock Chart
OCR Stock Chart
 Omnicare Inc. Stock News
OCR Stock News
 Omnicare Inc. Company Information
OCR Company Information
 Omnicare Inc. Stock Trades
OCR Stock Trades

Omnicare: US Criminal Probe Of Co Tied To DEA Audit

By Dinah Wisenberg Brin Of DOW JONES NEWSWIRES Federal prosecutors are conducting a criminal investigation of Omnicare Inc. (OCR) and several current and former employees in connection with U.S. Drug Enforcement Administration audits of controlled-substance dispensing paperwork, the nursing-home pharmacy disclosed Thursday. The DEA is investigating "alleged errors and deficiencies in paperwork requirements for controlled substance dispensing at several of the company's pharmacies in Ohio," the company said in its third-quarter financial report filed with the Securities and Exchange Commission. The U.S. Attorney's Office for the Northern District of Ohio is conducting a probe relating to the matter and may seek monetary penalties, Omnicare said. The same U.S. Attorney's office "is also conducting a criminal investigation of the company and several current and former employees in connection with the DEA audits," the Covington, Ky., company said. "The company is cooperating with these investigations and intends to vigorously defend itself if these matters are pursued." Controlled substances are tightly regulated or illegal drugs, some of which may be prescribed by a physician legitimately. Spokesmen for Omnicare and the U.S. attorney's office in Cleveland weren't immediately available for comment. Omnicare shares recently traded up 5.6% at $24.04. While the company swung to a third-quarter loss, earnings per share from continuing operations exceed Wall Street expectations. By Dinah Wisenberg Brin, Dow Jones Newswires, 215-656-8285; dinah.brin@dowjones.com

Stock News for Omnicare (OCR)
DateTimeHeadline
05/22/201520:00:00SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into...
05/22/201517:28:30Current Report Filing (8-k)
05/22/201517:26:20Additional Proxy Soliciting Materials (definitive) (defa14a)
05/22/201517:10:19Additional Proxy Soliciting Materials (definitive) (defa14a)
05/22/201510:57:00SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation...
05/22/201510:27:00Finkelstein Thompson LLP Investigates Potentially Unfair Buyout...
05/22/201510:08:00SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders...
05/21/201520:30:46For CVS, Big Bet On Pricey Medicines
05/21/201517:10:00WeissLaw LLP: Omnicare, Inc. Sale Under Legal Investigation
05/21/201516:49:40Additional Proxy Soliciting Materials (definitive) (defa14a)
05/21/201516:45:20Additional Proxy Soliciting Materials (definitive) (defa14a)
05/21/201516:43:07Current Report Filing (8-k)
05/21/201516:39:40Additional Proxy Soliciting Materials (definitive) (defa14a)
05/21/201516:05:43Omnicare Declares Quarterly Cash Dividend
05/21/201514:40:00Robbins Arroyo LLP: Acquisition of Omnicare Inc. (OCR) by CVS...
05/21/201514:09:00Harwood Feffer LLP Announces Investigation of Omnicare, Inc.
05/21/201513:52:00OMNICARE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces...
05/21/201513:22:00INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation...
05/21/201512:56:00OMNICARE INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe...
05/21/201510:23:08CVS to Buy Omnicare For $12.7 Billion--5th Update

Omnicare and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad